There were 1,561 press releases posted in the last 24 hours and 429,449 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Asceneuron Receives Regulatory Approval for Phase I Healthy Volunteer Study of Oral Tau Inhibitor

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image